Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia
NCT ID: NCT00833196
Last Updated: 2019-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
404 participants
OBSERVATIONAL
2009-02-28
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phase IV-Cervical Dystonia-INTEREST IN CD2
NCT01753349
Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]
NCT01840462
Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia
NCT05884528
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia
NCT01753336
A Trial of Non-invasive Stimulation in Cervical Dystonia
NCT04057911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* TWSTRS severity score ≥ 15
* At least a 12-week interval between the last injection (BoNT-A or BoNTB) and inclusion
* Written informed consent prior to collect the data
Exclusion Criteria
* Secondary cervical dystonia
* Subject already been included in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipsen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ipsen Medical Director
Role: STUDY_DIRECTOR
Ipsen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Prince Alfred Hospital
Camperdown, , Australia
St Vincent's Hospital
Fitzroy, , Australia
Austin Hospital
Heidelberg, , Australia
Westmead Hospital
Penrith, , Australia
Alfred Hospital
Prahran, , Australia
AZ Sint Jan Brugge
Bruges, , Belgium
UZ Gent
Ghent, , Belgium
Leuven, , Belgium
Centre Hospitalier de Liège, Domaine Universitaire Sart Tilmen
Liège, , Belgium
AZ Sint Augustinus Wilrijk
Wilrijk, , Belgium
Fakultní nemocnice U Sv.Anny
Brno, , Czechia
Fakultní nemocnice Olomouc
Olomouc, , Czechia
Krajská nemocnice Pardubice
Pardubice, , Czechia
Všeobecná fakultní nemocnice
Prague, , Czechia
Hôpital Neurologique et Neurochirurgical Pierre Wertheimer
Bron, , France
Hôpital Roger Salengro
Lille, , France
Hôpital La Timone
Marseille, , France
Hôpital Pasteur - CHU Nice
Nice, , France
Hôpital La Pitié Salpétrière
Paris, , France
Hôpital Haut Lévêque
Pessac, , France
Hôpital Purpan
Toulouse, , France
Praxis für Neurologie
Berlin, , Germany
Praxis für Neurologie
Bochum, , Germany
Praxis für Neurologie, International Neuroscience Institute
Hanover, , Germany
Praxis für Neurologie
Neusaß, , Germany
Praxis für Neurologie und Psychatrie
Schorndorf, , Germany
Krankenhaus der Barmherzigen Brüder
Trier, , Germany
Martini Ziekenhuis Groningen
Groningen, , Netherlands
Tergooiziekenhuizen Hilversum
Hilversum, , Netherlands
Hospital Santa Maria
Lisbon, , Portugal
Hospital General San Antonio - Centro Hospitalar do Porto
Porto, , Portugal
Serviço de Neurologia - Hospital de São João
Porto, , Portugal
16, ulitsa Vorovskogo
Chelyabinsk, , Russia
12a, ulitsa Karbyisheva
Kazan', , Russia
80, Volokolamskoye shossee
Moscow, , Russia
6/8, ulitsa L'va Tolstogo
Saint Petersburg, , Russia
Royal Devon & Exeter Hospital
Exeter, , United Kingdom
National Hospital for Neurology & Neurosurgery
London, , United Kingdom
Walton Centre for Neurology & Neurosurgery, Hope Hospital
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Trosch RM, Misra VP, Maisonobe P, Om S. Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice. Clin Park Relat Disord. 2020 Jun 15;3:100063. doi: 10.1016/j.prdoa.2020.100063. eCollection 2020.
Misra VP, Ehler E, Zakine B, Maisonobe P, Simonetta-Moreau M; INTEREST IN CD group. Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study. BMJ Open. 2012 Jun 14;2(3):e000881. doi: 10.1136/bmjopen-2012-000881. Print 2012.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Y-79-52120-131
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.